乔治临床( George Clinical ) congratulates its parent company, The George Institute for Global Health for securing a project grant that could transform the treatment of chronic kidney disease (CKD) […]
了解更多乔治临床( George Clinical ) welcomes the recognition of Professor Craig Anderson as profiled in the premier medical journal The Lancet which identified him as “a front runner in stroke resea […]
了解更多乔治临床( George Clinical ) welcomes the recent announcement by our partner organization, West Cancer Center of their intention to join OneOncology in January 2019. The announcement sees a departu […]
了解更多SYDNEY, January 22, 2019 – 乔治临床( George Clinical ), headquartered in Sydney, Australia, a global scientifically backed CRO, today announced the appointment of James Cheong to the role of Chief […]
了解更多乔治临床( George Clinical ) welcomes The Taiwan Food and Drug Administration’s (TFDA) recent clarified timelines for approval of a general Clinical Trial Authority (CTA) at 45 calendar days. […]
了解更多The importance of securing strong, long-standing investigator networks with leading research hospitals and clinics is critical to the continued growth of the clinical trial environment in coun […]
了解更多乔治临床( George Clinical ), a leading clinical research organization (CRO) in the Asia-Pacific region, has gained recognition of the organization’s strong support of the Mandatory Provident Fund […]
了解更多乔治临床( George Clinical ) welcomes the decision by the FDA to approve the delivery of CAR-T therapy in a partnership between Methodist Healthcare, and 乔治临床( George Clinical ) Scientific Leader, […]
了解更多Beijing, November 13, 2018 – 乔治临床( George Clinical ), a leading clinical research organization (CRO) in the Asia-Pacific region, has continued its involvement and collaboration with the Heart […]
了解更多9 AUGUST, 2018 – (BEIJING) In another positive development in China’s rapidly evolving regulatory environment The China National Drug Administration (CNDA) has introduced a 60-day window […]
了解更多
